Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea
- 1 March 2007
- journal article
- clinical trial
- Published by Elsevier in American Journal of Infection Control
- Vol. 35 (2), 131-137
- https://doi.org/10.1016/j.ajic.2006.06.007
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, CanadaClinical Infectious Diseases, 2005
- Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with MetronidazoleClinical Infectious Diseases, 2005
- Clostridium difficile-associated diarrhea in adultsCMAJ : Canadian Medical Association Journal, 2004
- Clostridium difficile-Associated Diarrhea and ColitisMayo Clinic Proceedings, 2001
- Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective studyJournal of Antimicrobial Chemotherapy, 2001
- Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoeaThe Lancet, 2001
- Asymptomatic Carriage ofClostridium difficileand Serum Levels of IgG Antibody against Toxin ANew England Journal of Medicine, 2000
- ASHP Therapeutic Position Statement on the Preferential Use of Metronidazole for the Treatment of Clostridium difficile-Associated DiseaseAmerican Journal of Health-System Pharmacy, 1998
- Clostridium Difficile-Associated Diarrhea and ColitisInfection Control & Hospital Epidemiology, 1995
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989